CEO: Michael Taylor

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Deciphera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing new drugs to improve the lives of cancer patients.


Key numbers

Market Capitalization:3381658375
Shares Outstanding: 51043900
Float: 31204259
Next Earning Date:2020-03-25
TTm EPS: -3.9473
TTm Dividend Rate:
200 days moving average:36.28
50 days moving average: 58.19
One day percent Change: 0.14



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,